ArticleJournal of surgical case reports2025
Late-onset esophagogastric anastomotic fistula managed without continuous fasting: a case report.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophagogastric anastomotic fistula is a common complication following esophageal cancer surgery, typically occurring within the first postoperative week. Conventional management requires prolonged fasting until complete fistula closure, which significantly impacts patient quality of life. We present a case of a male who developed an esophagogastric anastomotic fistula 2 months postoperatively, complicated by a concurrent gastrobronchial fistula. Endoscopic evaluation revealed persistent gastric wall defects at the fistula site. As the disease progressed, thickened visceral pleura formed dense adhesions with the damaged gastric tissue, effectively sealing the defect and preventing digestive fluid leakage into the thoracic cavity. By promptly promoting gastric emptying and reducing gastric acid secretion, the patient resumed oral intake without developing severe infections or complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.